Hidradenitis Suppurativa Clinical Trials in Miami, Florida

3 studies are recruiting for hidradenitis suppurativa in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

    The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe hidradenitis suppurativa (HS) who have completed either of the preceding Phase 3 studies, CLOU064J12301 or CLOU064J12302.

    Stage
    Phase 3
    Ages
    18 to 100
    Site
    Floridian Research Institute, Miami, Florida
    Locations
    34 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07665437 on ClinicalTrials.gov

  2. A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

    This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR445399 in adult participants with moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the efficacy and safe…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Fxm Clinical Research/Fax Pharma Clinical Research- Site Number : 8400014, Miami, Florida
    Locations
    83 in total
    Run by
    Sanofi

    See if you can join NCT07225569 on ClinicalTrials.gov

  3. Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

    This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of the main study is to assess the efficacy and safety of brivekimig in a dose-ranging …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    FXM Clinical Research - Miami- Site Number : 8400017, Miami, Florida
    Locations
    79 in total
    Run by
    Sanofi

    See if you can join NCT07170917 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.